Australian IT Stock News

Earlier in May 2026, Telix Pharmaceuticals reported that its Phase 1 IPAX-2 trial of TLX101-Tx for newly diagnosed glioblastoma completed enrolment, with no dose-limiting toxicities observed so far at doses up to 10GBq alongside standard-of-care therapy. This progress, together with ongoing Phase 3 evaluation of TLX101-Tx as the first radiopharmaceutical therapy to reach this stage in glioblastoma, highlights Telix’s attempt to build a differentiated neuro-oncology franchise using...

The Hydration Pharmaceuticals Company Limited's (ASX:HPC) stock rose 33% last week, but insiders who sold US$205m worth...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Markets are being pulled in different directions by geopolitics, energy prices and shifting interest rate expectations, and it can feel hard to know where to focus. One approach is to build around companies that aim to be resilient when conditions change. Our Low-Risk Leaders screener targets stocks with strong balance sheets and low model risk scores, designed to help reduce volatility while still keeping you in the market. In this article, you will see three stocks from that screener and...

Retail Food Group Limited's (ASX:RFG) value has fallen 10% in the last week, but insiders who sold AU$523k worth of...

Breville Group Limited ( ASX:BRG ), might not be a large cap stock, but it saw a decent share price growth of 16% on...

Investors who take an interest in Spacetalk Limited ( ASX:SPA ) should definitely note that the Independent...

As the Australian market holds steady, awaiting key inflation data amid global volatility in oil prices and mixed signals from international markets, investors are keenly observing sectors that promise growth potential. In this context, companies with high insider ownership can offer unique insights into future performance, as insiders who have significant stakes often align their interests closely with those of other shareholders.

As the Australian market holds steady, awaiting key economic data like the anticipated April inflation print, investors are keenly observing how these developments might impact stock valuations. In this environment, identifying stocks trading below their intrinsic value can present opportunities for those looking to capitalize on potential market inefficiencies.

As the Australian market holds steady, awaiting key inflation data, the broader sentiment remains cautious amid global economic shifts and volatile commodity prices. In this environment, identifying promising small-cap stocks requires a keen eye for potential growth drivers and resilience in challenging conditions.

As the Australian market holds steady, waiting for crucial inflation data, investors are keeping a close eye on potential opportunities amidst global economic shifts. Penny stocks, a term that may seem outdated but remains relevant, represent smaller or newer companies with potential for growth and value. By focusing on those with strong financials and clear growth trajectories, investors can uncover promising opportunities in this unique segment of the market.

Pro Medicus (ASX:PME) has drawn fresh attention after announcing the planned resignation of Clayton Hatch, Head of Business Operations and Investor Relations, who previously served as long-time Chief Financial Officer. See our latest analysis for Pro Medicus. The executive change comes as Pro Medicus trades at A$130.6, with the share price up 2.6% over the past day and 1.5% over the week but down 41.3% year to date. The 1 year total shareholder return has declined 53.5%, while longer term 3...

Wondering if Worley at A$12.94 is offering fair value or if the price is getting ahead of itself? This article explains what the current share price might be indicating. Over the past week the stock has returned 6.5%, with 9.5% over the last month and 3.1% year to date, while the 1 year return is 3.5% and the 3 year return shows a decline of 12.0% compared to a 38.3% gain over 5 years. Recent news flow around Worley has focused on its role as an engineering and consulting provider to energy...

ALS Limited (ASX:ALQ) recently reported full-year results to March 31, 2026, with revenue of A$3,320.1 million and net income of A$318.7 million, alongside reaffirmed focus on acquisitions that meet strict return hurdles. Management’s insistence on only pursuing bolt-on deals that can reach a 15% return on capital employed by year five offers insight into how ALS balances growth ambitions with disciplined capital allocation. We’ll now explore how this earnings performance and disciplined 15%...

Commonwealth Bank of Australia (ASX:CBA) has appointed Professor Mary-Anne Williams as its first Chief AI Scientist, tasked with overseeing AI research, talent, and implementation across the bank. The bank is trialing an AI-powered customer support agent, Companion, within its app as part of a broader push to embed AI in customer interactions. CEO Matt Comyn has outlined expectations for AI driven workforce changes at CBA and across the wider economy, alongside public engagement on AI with...

Web Travel Group (ASX:WEB) has reported H1 2026 revenue of A$204.6 million with basic EPS of A$0.074, setting a clear snapshot of its recent trading performance. Over the last three reported half years, revenue has moved from A$170.4 million in H1 2025 to A$158 million in H2 2025 and then to A$204.6 million in H1 2026. Over the same periods, basic EPS has shifted from A$0.096 in H1 2025 to a loss of A$0.069 per share in H2 2025 before landing at A$0.074 in the latest period. Together, these...

Aroa Biosurgery (ASX:ARX) has just reported FY 2026 first half revenue of NZ$44.9 million, with a reported loss of NZ$1.3 million and basic EPS of NZ$0.0038 loss, while the trailing twelve months show revenue of NZ$103.9 million and net income of NZ$4.7 million translating to basic EPS of NZ$0.0135. Over recent periods the company has seen revenue move from NZ$39.2 million in 1H FY 2025 to NZ$45.5 million in 2H FY 2025, alongside EPS shifting from NZ$0.0096 loss to NZ$0.0015 loss. Together,...

Goodman Group held its Q3 2026 operating results call on May 26, 2026, giving investors an updated view of its recent financial and operational performance. This call is especially important for stakeholders watching how Goodman’s heavy push into data centers and modern logistics is progressing within its broader infrastructure portfolio. Next, we’ll explore how insights from the Q3 2026 operating results call may shape Goodman Group’s data center-focused investment narrative. Find 9...

Greatland Resources (ASX:GGP) has received all primary environmental approvals for its Havieron gold copper project in Western Australia. The approvals cover both state and federal levels, clearing a key regulatory hurdle for the project. This milestone keeps Havieron on track for a Final Investment Decision targeted for this quarter. For you as an investor, this approval step confirms that Greatland Resources, a gold and copper focused company, can move Havieron further along the...

ASX (ASX:ASX) is back in focus after announcing that Anthony Attia will become CEO and Managing Director from 1 September 2026, a move that highlights leadership experience for investors. See our latest analysis for ASX. The leadership announcement comes after a sharp reset in sentiment, with the share price down 13.2% over the past day and 14.4% over the past month. The 1 year total shareholder return has fallen 25.7%, signalling pressure rather than building momentum, despite longer term...

Recent commentary highlights that Generation Development Group, through its subsidiary Generation Life, has reinforced its position as Australia's leading provider of investment bonds, supported by strong adviser uptake and growing structural demand tied to intergenerational wealth transfer and superannuation caps. The company is also broadening its reach into adjacent wealth segments, including retirement income solutions and selective funds management offerings, potentially deepening its...

As the Australian market holds steady, awaiting crucial inflation data, investors are keenly observing potential opportunities amidst a backdrop of global volatility and local economic anticipation. Penny stocks, often seen as relics of past market eras, continue to offer intriguing prospects for those seeking growth at accessible price points. By focusing on companies with strong financial health and clear growth potential, investors can uncover hidden gems in this often overlooked segment...

Deterra Royalties (ASX:DRR) is back in focus after reporting higher revenue and net profit, with investor attention centering on steady Mining Area C royalties and growing lithium exposure via the Thacker Pass project. See our latest analysis for Deterra Royalties. The stock is trading at A$4.68 after a 15.84% 1 month share price return and a 32.37% 1 year total shareholder return. This suggests momentum has picked up as investors react to higher reported revenue, net profit, and interest in...

Codan’s transition under the spotlight Codan (ASX:CDA) is back in focus after recent commentary highlighted its transition into a diversified global technology supplier, shaped by new defence contracts and rising demand for humanitarian demining solutions. See our latest analysis for Codan. At a latest share price of A$41.26, Codan’s recent 30 day share price return of 15.77% and very large 3 year total shareholder return suggest momentum has been building as investors reassess growth...